Now, Organon — Merck’s spin-off business that focuses on women’s health — has launched a campaign celebrating romantasy’s appeal to its target audience. The recently-unveiled campaign supports ...

A still from the "Rromantasy" commercial (Organon) The ad ends with a final nod to the genre, with the claim that Nexplanon is “over 99% effective, no matter the fantasy.” Organon pledges $30M ...

Organon's Q1 2025 earnings report showed significant declines across key financial metrics, leading to a drastic 30% drop in share price following a >90% dividend cut. The company's revenue ...

Organon, a women’s health-focused pharma company based in Jersey City, expects to eliminate 93 jobs as part of an effort to optimize internal operations. In a filing with the state Department of ...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its fourth quarter and full year 2024 financial results on ...

TD Cowen analyst Michael Nedelcovych took over primary coverage of Organon (OGN) with a Hold rating and $19 price target Organon presented business updates that provide some insight into the 2025 ...

Cairo, Egypt:Organon, a global healthcare company dedicated to advancing women’s health, announced the signing of a Memorandum of Understanding (MOU) with the Egyptian Drug Authority (EDA). This ...

Organon Philippines, a women’s health company, recently unveiled its Her Health Finder, an online tool that aims to empower women to take control of their health by providing quick, easy access ...

On World Contraception Day, Organon, a pharmaceutical company focused on women’s health, ignited discussions on women’s reproductive health and their right to choose at the recently held event ...

Please provide your email address to receive an email when new articles are posted on . Organon is an independent global health care company dedicated to promoting women’s health. Organon will ...

Organon, a global healthcare company with a focus on women’s health, released its 2023 Environmental, Social and Governance (ESG) Report Organon (NYSE: OGN), a global healthcare company with a focus ...